FIDA Biosystems is an innovative biotechnology company whose patented Fluid Dynamics Dispersion (FIDA) technology characterizes the behavior and characteristics of biomolecules by directly obtaining absolute fluid dynamics radius (Rh) changes based on first principles of physics. The latest product launched by FIDA Biosystems, Fida Neo, covers three major functions: affinity characterization, affinity kinetics characterization, and molecular mass characterization. It is the only biophysical analysis platform in the world that integrates multiple molecular structures, functions, and quality control characterization. Data on interactions and molecular quality control can be obtained in one experiment, providing a reliable basis for interaction data. FIDA technology does not require fixation, heating, or even labeling, and is compatible with all buffers. Due to its first principles characterization, it is a revolutionary upgrade to existing molecular interaction technologies.
Since its release in 2019, FIDA has had nearly a hundred clients worldwide, distributed in high-level research institutes, universities, and leading biopharmaceutical companies worldwide. Premedical Laboratories Co., Ltd. established a cooperative relationship with FIDA Biosystems in May 2024, officially becoming the general agent for its entire product line in China. In the future, Premedlab will provide FIDA products and services to Chinese users. Primordia will work together with Chinese molecular interaction and stability related research users to provide high-level scientific research assistance to China.
- Conference Preview | Premedlab invites you to attend the 12th Munich Shanghai Analytical Biochemistry Exhibition
- Conference Preview | PremedLab invites you to attend the Beijing Yizhuang Summit on Cell Genes and Nucleic Acid Drugs
- Conference Preview | PremedLab invites you to attend the 14th Annual Meetting of CSSCR
- Binaree Organization Transparency Reagent - Summer Promotion Begins!
- The new high-precision SPR detection platform for 2024 is here!!
- Meeting Announcement | Premedlab cordially invites you to participate in the 2nd Molecular Interaction Innovation Technology and Frontier Application Network Seminar
- Application for limited time of Corebiogenesis trial installation | GMP grade FGF-2 STAB with no animal source, thermal stability, and high activity - new gold standard for stem cell culture
- CELLnTEC new product launch | Corticosteroid free epithelial cell proliferation medium
